# Query Results

**Query:** mergers and acquisitions

**Timestamp:** 20251020_025632

**Top K:** 5

**Results Found:** 5

---

## Result 1

**Similarity Score:** 0.4336 | **Semantic:** 0.6195 | **Keyword:** 0.0000 | **Rerank:** 3.5245

**Source:** martiniai.md

**Chunk ID:** 32

**Content:**

```
more stable outlook for investors and creditors. Furthermore, there have been no publicly disclosed merger or acquisition (M&A) activities involving IBA 145. The absence of M&A transactions suggests that IBA is maintaining its current business structure and strategic direction. This can be interpreted as a sign of stability, as M&A activities often introduce integration risks, management distractions, and potential financial strain.
```

---

## Result 2

**Similarity Score:** 0.4377 | **Semantic:** 0.5896 | **Keyword:** 0.0833 | **Rerank:** 3.4676

**Source:** ion-beam-applications-sa-financial-ratios-10-years-financial-data-marketscreener.md

**Chunk ID:** 27

**Content:**

```
legal-risks/ "Legal risks")
[Share buybacks](https://www.marketscreener.com/news/companies/share-buybacks/ "Share buybacks")
[Mergers and acquisitions](https://www.marketscreener.com/news/companies/mergers-acquisitions/ "Mergers and acquisitions")
[Call Transcripts](https://www.marketscreener.com/news/companies/call-transcripts/ "Call Transcripts")
[Guidance](https://www.marketscreener.com/news/companies/guidance/ "Guidance")
[Indices](https://www.marketscreener.com/news/indexes/ "Indices")
[Cur
```

---

## Result 3

**Similarity Score:** 0.4267 | **Semantic:** 0.5892 | **Keyword:** 0.0476 | **Rerank:** 2.4354

**Source:** ion-beam-applications-sa-financial-ratios-10-years-financial-data-marketscreener.md

**Chunk ID:** 91

**Content:**

```
companies/legal-risks/ "News - ")
 * [Share buybacks](https://www.marketscreener.com/news/companies/share-buybacks/ "News - ")
 * [Mergers and acquisitions](https://www.marketscreener.com/news/companies/mergers-acquisitions/ "News - ")
 * [Call Transcripts](https://www.marketscreener.com/news/companies/call-transcripts/ "News - ")
 * [Guidance](https://www.marketscreener.com/news/companies/guidance/ "News - ")
 * [Indices](https://www.marketscreener.com/news/indexes/ "News - ")
 * [Currency / Fo
```

---

## Result 4

**Similarity Score:** 0.3809 | **Semantic:** 0.5325 | **Keyword:** 0.0273 | **Rerank:** -2.4571

**Source:** pdf-innovative-leadership-comparison-of-ion-beam-applications-sa-belgium-against-its-competitors.md

**Chunk ID:** 69

**Content:**

```
ramework. SDGs it still needs to i
A 
Table VIII. As ofHitachis the
company intend to increase the added value of Hitachis
particle 
organic 
investment 
carrying out Mergers and Acquision. Consequently from 
2018 to 2021 Hitachi carried out almost 10 Mergers and 
Acquisions. From FY 2021, Hitachi is investing JYP 300 
bn in in-vitro 
pharmaceutical solutions, In 
accelerator 
open 
According to
Hitachi uses in of Mergers 
and to
achieve 
summary of Hitachis strategies and policies are given in
Table. IX. Siemens Healthineers 
such 
education, [8].
```

---

## Result 5

**Similarity Score:** 0.3654 | **Semantic:** 0.5148 | **Keyword:** 0.0167 | **Rerank:** -4.7403

**Source:** medires.md

**Chunk ID:** 103

**Content:**

```
strategies and policies are listed in Table VIII. As part of Hitachis growth investment strategy, the company intend to increase the added value of Hitachis particle beam therapy system [24]. This falls under organic growth. Hitachi also intend to increase growth investment by increasing inorganic growth such as by carrying out Mergers and Acquision. Consequently from 2018 to 2021 Hitachi carried out almost 10 Mergers and Acquisions. From FY 2021, Hitachi is investing JYP 300 bn in cancer Radiotherapy, in-vitro diagnosis, pharmaceutical solutions, and medical data integration.
```

---

